CTSO
Cytosorbents Corp
Key Financials
Gross Profit
$26.5M
↑ 5.4%
Net Income
$-8198000
↑ 60.4%
Operating Income
$-14749000
↑ 12.1%
Revenue
$18.5M
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 8/14/2026 | View on SEC |
| 8-K | 8/7/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| 10-Q | 8/6/2026 | View on SEC |
| 8-K | 7/6/2026 | View on SEC |
| ARS | 6/25/2026 | View on SEC |
| DEFA14A | 6/25/2026 | View on SEC |
| DEF 14A | 6/25/2026 | View on SEC |
| 8-K | 6/25/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CTSO |
| Company Name | Cytosorbents Corp |
| CIK | 1175151 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 973-329-8885 |